Infrared spectroscopy to detect and manage COPD
This article was originally published in Start Up
Chronic obstructive pulmonary disease remains a particularly difficult disease to accurately diagnose, with little improvement over the last 30 years. UK-based Glyconics Ltd. hopes to reliably detect COPD with an easy, five-minute, in-office procedure that uses a sputum sample to identify a handful of proprietary biomarkers specific for the disease.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.